These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36642429)

  • 1. The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics.
    Java A; Kim AHJ
    J Rheumatol; 2023 Jun; 50(6):730-740. PubMed ID: 36642429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
    Che M; Moran SM; Smith RJ; Ren KYM; Smith GN; Shamseddin MK; Avila-Casado C; Garland JS
    Kidney Int; 2024 May; 105(5):960-970. PubMed ID: 38408703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
    Ono M; Ohashi N; Namikawa A; Katahashi N; Ishigaki S; Tsuji N; Isobe S; Iwakura T; Sakao Y; Tsuji T; Kato A; Fujigaki Y; Shimizu A; Yasuda H
    Intern Med; 2018 Jun; 57(11):1617-1623. PubMed ID: 29434134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated thrombotic microangiopathy associated with lupus nephritis.
    Park MH; Caselman N; Ulmer S; Weitz IC
    Blood Adv; 2018 Aug; 2(16):2090-2094. PubMed ID: 30131343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus.
    Kotzen ES; Roy S; Jain K
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):376-386. PubMed ID: 31733722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.
    Saleem M; Shaikh S; Hu Z; Pozzi N; Java A
    Front Immunol; 2022; 13():909503. PubMed ID: 35720299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
    Hanna RM; Henriksen K; Kalantar-Zadeh K; Ferrey A; Burwick R; Jhaveri KD
    Adv Chronic Kidney Dis; 2022 Mar; 29(2):149-160.e1. PubMed ID: 35817522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.
    Kello N; Khoury LE; Marder G; Furie R; Zapantis E; Horowitz DL
    Semin Arthritis Rheum; 2019 Aug; 49(1):74-83. PubMed ID: 30598332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.
    Wright RD; Bannerman F; Beresford MW; Oni L
    BMC Nephrol; 2020 Jun; 21(1):245. PubMed ID: 32605540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
    de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP
    Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.
    Gavriilaki E; Anagnostopoulos A; Mastellos DC
    Front Immunol; 2019; 10():337. PubMed ID: 30891033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab.
    Cammett TJ; Garlo K; Millman EE; Rice K; Toste CM; Faas SJ
    Mol Diagn Ther; 2023 Jan; 27(1):61-74. PubMed ID: 36329366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient.
    Kaneda T; Tanaka E; Akutsu Y; Kanamori T; Mouri M; Morio T; Mori M
    CEN Case Rep; 2020 Nov; 9(4):301-307. PubMed ID: 32304042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
    Sridharan M; Go RS; Willrich MAV
    J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
    PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome.
    Shen YM
    Thromb J; 2016; 14(Suppl 1):19. PubMed ID: 27766045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of von Willebrand factor in thrombotic microangiopathy.
    Noone DG; Riedl M; Licht C
    Pediatr Nephrol; 2018 Aug; 33(8):1297-1307. PubMed ID: 28748411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.
    Lee H; Kang E; Kang HG; Kim YH; Kim JS; Kim HJ; Moon KC; Ban TH; Oh SW; Jo SK; Cho H; Choi BS; Hong J; Cheong HI; Oh D
    Korean J Intern Med; 2020 Jan; 35(1):25-40. PubMed ID: 31935318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.